SERPATE Drug Patent Profile
✉ Email this page to a colleague
When do Serpate patents expire, and what generic alternatives are available?
Serpate is a drug marketed by Vale and is included in one NDA.
The generic ingredient in SERPATE is reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine profile page.
Summary for SERPATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 101 |
Patent Applications: | 1,212 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SERPATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SERPATE
US Patents and Regulatory Information for SERPATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vale | SERPATE | reserpine | TABLET;ORAL | 009453-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Vale | SERPATE | reserpine | TABLET;ORAL | 009453-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |